Literature DB >> 11684396

Vitamin K and bone health.

P Weber1.   

Abstract

In the past decade it has become evident that vitamin K has a significant role to play in human health that is beyond its well-established function in blood clotting. There is a consistent line of evidence in human epidemiologic and intervention studies that clearly demonstrates that vitamin K can improve bone health. The human intervention studies have demonstrated that vitamin K can not only increase bone mineral density in osteoporotic people but also actually reduce fracture rates. Further, there is evidence in human intervention studies that vitamins K and D, a classic in bone metabolism, works synergistically on bone density. Most of these studies employed vitamin K(2) at rather high doses, a fact that has been criticized as a shortcoming of these studies. However, there is emerging evidence in human intervention studies that vitamin K(1) at a much lower dose may also benefit bone health, in particular when coadministered with vitamin D. Several mechanisms are suggested by which vitamin K can modulate bone metabolism. Besides the gamma-carboxylation of osteocalcin, a protein believed to be involved in bone mineralization, there is increasing evidence that vitamin K also positively affects calcium balance, a key mineral in bone metabolism. The Institute of Medicine recently has increased the dietary reference intakes of vitamin K to 90 microg/d for females and 120 microg/d for males, which is an increase of approximately 50% from previous recommendations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684396     DOI: 10.1016/s0899-9007(01)00709-2

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  28 in total

Review 1.  Vitamin K in cystic fibrosis.

Authors:  S P Conway
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

2.  Are milk and alternatives and fruit and vegetable intakes during adolescence associated with cortical and trabecular bone structure, density, and strength in adulthood?

Authors:  E Z Movassagh; S Kontulainen; A D G Baxter-Jones; S Whiting; M Szafron; M Papadimitropoulos; H Vatanparast
Journal:  Osteoporos Int       Date:  2016-10-03       Impact factor: 4.507

3.  Effect of GGCX gene polymorphism on the responses of serum undercarboxylated osteocalcin and bone turnover markers after treatment with vitamin K2 (menatetrenone) among postmenopausal Thai women.

Authors:  Thawee Songpatanasilp; La-or Chailurkit; Suwannee Chantprasertyothin; Boonsong Ongphiphadhanakul; Nimit Taechakraichana
Journal:  J Bone Miner Metab       Date:  2011-02-23       Impact factor: 2.626

4.  Nutrient selection and optimization to formulate a nutrient bar stable on storage and specific to women at risk of osteoporosis.

Authors:  Rafiya Munshi; Anita Kochhar; Amarjeet Kaur
Journal:  J Food Sci Technol       Date:  2020-03-19       Impact factor: 2.701

5.  Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Authors:  Nina Emaus; Nguyen D Nguyen; Bjørg Almaas; Gro K Berntsen; Jacqueline R Center; Monika Christensen; Clara G Gjesdal; Anne S Grimsgaard; Tuan V Nguyen; Laila Salomonsen; John A Eisman; Vinjar M Fønnebø
Journal:  Eur J Nutr       Date:  2011-11-30       Impact factor: 5.614

Review 6.  Production and application of menaquinone-7 (vitamin K2): a new perspective.

Authors:  Ehsan Mahdinia; Ali Demirci; Aydin Berenjian
Journal:  World J Microbiol Biotechnol       Date:  2016-11-10       Impact factor: 3.312

7.  Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys.

Authors:  Fang-Fei Wei; Nadja E A Drummen; Lutgarde Thijs; Lotte Jacobs; Marjolein Herfs; Cynthia Van't Hoofd; Cees Vermeer; Jan A Staessen
Journal:  Pulse (Basel)       Date:  2016-08-24

8.  Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism.

Authors:  L A Martini; S L Booth; E Saltzman; M do Rosário Dias de Oliveira Latorre; R J Wood
Journal:  Osteoporos Int       Date:  2006-03-18       Impact factor: 4.507

Review 9.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

Review 10.  Bone health and associated metabolic complications in neuromuscular diseases.

Authors:  Nanette C Joyce; Lauren P Hache; Paula R Clemens
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.